VetCell Bioscience's pioneering stem cell technique, which is used to return injured horses to top levels of performance, will be tested in human medicine. The trials will be conducted by VetCell's parent company MedCell Bioscience Ltd under the guidance of David Glover, MD, former medical director of Cambridge Antibody Technologies, Professor Nicola Maffulli, MD, MS, PhD, FRCS(Orth), one of
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
